PER 0.00% 8.0¢ percheron therapeutics limited

Ann: US FDA Type C Meeting for ATL1102 in DMD, page-17

  1. 13,162 Posts.
    lightbulb Created with Sketch. 1383
    Now we know why many great Biotech minds have joined Anp...The recent Data is superb giving hope to many DMD sufferers and also the new indications to follow....Market for Inflammation is $1.1 Billion...
    Its safe to say Atl1102 will have a market well over $200 billion..
    Is Anp the next CSL..... I say YES $$
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.0¢ 8.1¢ 7.7¢ $93.21K 1.183M

Buyers (Bids)

No. Vol. Price($)
1 145811 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 33389 1
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.